50% off on annual subscription with code BIOTECH | Offer ends May 30th

CRISPR: Revolutionising Genome Editing

This advanced-level course is designed to develop an understanding of complex concepts related to genomics, particularly CRISPR/Cas technology and its applications in drug discovery, therapeutics and much more.


Starts 29th May 2024

About This Course

This course provides in-depth knowledge of CRISPR/Cas technology and various concepts in genomics such as cell manipulation, DNA repair, gene cloning, reverse transcriptase, and several others. In addition to advanced-level learning on the CRISPR/Cas9 system, this course provides an overview of other CRISPR systems and variants. The limitations and challenges of the technology are discussed, along with its prospects to provide a complete overview of the topic to the learners. Various applications of CRISPR/Cas9 technology have been discussed including drug discovery, therapeutics, agriculture, animal farming, biofuels, and gene drive mechanisms. The course also includes CRISPR/Cas-based COVID detection and therapeutic approaches. A dedicated module in this course will help you to learn how to design your own CRISPR experiment so that the knowledge gained from the course can be translated to laboratory settings. Commonly used CRISPR tools, software, and obtaining gene sequences from the NCBI database have been elaborated to assist researchers with their CRISPR-based experiments. The course also discusses the career opportunities in this field, the key companies using the technology, and the skills that can help to build a successful career in genome editing.

Who Is This Course For

This advanced course is designed for a wide range of professionals with a background in bioscience and preferably with a basic knowledge of CRISPR/Cas technology. Undergraduate or graduates and postgraduate scholars, researchers, academicians such as lecturers and professors, investors or venture capitalists, policymakers, and other industry professionals who are capable of self-learning are likely to benefit from this course. The course will also be beneficial to those looking for career opportunities in the field of CRISPR/Cas technology and genomics.

What you'll learn

  • Learn complex and advanced concepts related to genomics and CRISPR/Cas technology
  • Explore the diverse applications of CRISPR/Cas technology
  • Learn about the ethical issues and lesser-known facts of CRISPR/Cas technology
  • Learn to design your own CRISPR experiment
  • Become aware of the career opportunities in this field

Course Content

Expand All

Meet Your Instructor

Dr. Christos Evangelou

Ph.D. in Cancer Biology, Division of Molecular and Clinical Cancer Sciences, University of Manchester, UK. Areas of expertise include cancer immunology, melanoma research, cancer immunotherapy, and mechanisms of immunotherapy resistance. During my Ph.D. research, I studied the role of chronic inflammation and cytokine IFN-gamma in adaptation and immunotherapy resistance in melanoma. By integrating high-throughput transcriptomic analyses and employing various cancer cell lines and animal models, I have developed methods to predict response to immunotherapy in melanoma patients. During my research, I have used the CRISPR/Cas9 system to knockout genes in human and mouse cell lines to assess the role of certain genes in immunotherapy resistance in melanoma.

Dr. Veronica Hughes

Veronica Hughes received her Ph.D. in medical science from the University of Florida. Her primary interest was cancer metastasis, dysregulation of the tumour microenvironment, and analysis of clinical trial design. Additionally, she engaged in the development of novel small animal models.

Dr. Matthias Schröder

Ph.D. in Immunology at the Division of Immunopharmacology of the University Clinic of Frankfurt am Main. Involved in basic and applied research for immunological interventions to treat cancer for 13 years. Matthias used a high-throughput CRISPR/Cas9 approach to generate a library of knockout cells that could be differentiated into immunosuppressive cells to investigate the potential loss of function situations. Currently involved in the development of fusion proteins to activate receptors of the TNF-superfamily (CD40, CD27, etc.) at a small German Biotech company as Head of Assay Development.

Our Partners

We are proud to partner with the leading In2scienceUK as a step towards achieving our mission of imparting quality education and knowledge across the globe.

Interested In This Course For Your Organisation?

Train your employees and/or students in the most in demand topics, with CBEHx for Business and School.

Upskill your organisation with CBEHx for Business and witness your company grow and succeed with online learning support.

The CBEHx for School domain empowers universities, schools, and other educational organizations with career-targeted transformative knowledge and skill development programs.

Common articles

Do you have any question? Please visit our Help Centre

Grow better with the right option, click here to view pricing. 

Usually, there are no general prerequisites when enrolling for any individual courses on cbehx.co.uk. However, some courses are certainly more advanced than others that are of introductory and intermediate level. For advanced-level courses, prior knowledge on the topic will be helpful for understanding complex concepts but not mandatory.

The relevant information about the suggested knowledge and background that might be helpful to follow each course is provided on the respective course registration page.

Yes, the courses are flexible and self-paced to suit your schedule. The term “self-paced” implies that the courses do not follow a pre-assigned schedule for learning within the course duration. You will be able to access all the course materials for each course that you have enrolled in as soon as the course begins.

The course completion certificate is CPD accredited. For more informations please visit https://cpduk.co.uk

Register For The Course and Get the eBook

Students registering for our program will receive our complimentary eBook with title: The Revolution of The CRISPR-Cas9 System.